⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9830633 | 0.79 | — | — | |
| SCHEMBL680633 | 0.76 | — | — | |
| SCHEMBL7996347 | 0.76 | — | — | |
| SCHEMBL12204156 | 0.76 | GABBR2 (0.40) | — | |
| SCHEMBL9522198 | 0.76 | TOP2A (0.45) | — | |
| SCHEMBL12711981 | 0.72 | GABBR2 (0.38) | — | |
| SCHEMBL1239420 | 0.72 | — | — | |
| SCHEMBL7036365 | 0.70 | GABBR2 (0.37) | — | |
| SCHEMBL20032385 | 0.70 | GABBR2 (0.49) | — | |
| SCHEMBL15898103 | 0.70 | DAO (0.45) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3590942-B1 | HEPATITIS B VIRUS SURFACE ANTIGEN INHIBITOR | FUJIAN COSUNTER PHARMACEUTICAL CO LTD (CN) | 2021-06-09 | — | — | EP | disclosed |
| EP-3590942-B1 | HEPATITIS B VIRUS SURFACE ANTIGEN INHIBITOR | FUJIAN COSUNTER PHARMACEUTICAL CO LTD (CN) | 2021-06-09 | — | — | EP | disclosed |
| US-11008331-B2 | Hepatitis B virus surface antigen inhibitor | FUJIAN COSUNTER PHARMACEUTICAL CO., LTD. (CN) | 2021-05-18 | — | — | US | disclosed |
| US-11008331-B2 | Hepatitis B virus surface antigen inhibitor | FUJIAN COSUNTER PHARMACEUTICAL CO., LTD. (CN) | 2021-05-18 | — | — | US | disclosed |
| US-20200039995-A1 | HEPATITIS B VIRUS SURFACE ANTIGEN INHIBITOR | FUJIAN COSUNTER PHARMACEUTICAL CO., LTD. (CN) | 2020-02-06 | — | — | US | disclosed |
| US-20200039995-A1 | HEPATITIS B VIRUS SURFACE ANTIGEN INHIBITOR | FUJIAN COSUNTER PHARMACEUTICAL CO., LTD. (CN) | 2020-02-06 | — | — | US | disclosed |
| CN-109071564-B | Hepatitis B virus surface antigen inhibitors | 福建广生堂药业股份有限公司 | 2019-08-27 | — | — | CN | disclosed |
| CN-109071564-A | Hepatitis B virus surface antigen inhibitors | 福建广生堂药业股份有限公司 | 2018-12-21 | — | — | CN | disclosed |
| US-20160257697-A1 | THIOPHENE-SUBSTITUTED TETRACYCLIC COMPOUNDS AND METHODS OFUSE THEREOF FOR THE TREATMENT OF VIRAL DISEASES | MERCK SHARP & DOHME CORP. (US) | 2016-09-08 | — | — | US | disclosed |
| US-20160257697-A1 | THIOPHENE-SUBSTITUTED TETRACYCLIC COMPOUNDS AND METHODS OFUSE THEREOF FOR THE TREATMENT OF VIRAL DISEASES | MERCK SHARP & DOHME CORP. (US) | 2016-09-08 | — | — | US | disclosed |
| WO-2014110706-A1 | THIOPHENE-SUBSTITUTED TETRACYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR TREATMENT OF VIRAL DISEASES | MERCK SHARP & DOHME CORP. (US) | 2014-07-24 | — | — | WO | disclosed |
| WO-2014110688-A1 | THIOPHENE- SUB STITUED TETRACYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES | MERCK SHARP & DOHME CORP. (US) | 2014-07-24 | — | — | WO | disclosed |
| CN-103459399-A | Tetracyclic indole derivatives for the treatment of hepatitis C virus infection | MERCK SHARP & DOHME | 2013-12-18 | — | — | CN | disclosed |
| EP-2621931-A1 | TETRACYCLIC INDOLE DERIVATIVES FOR TREATING HEPATITIS C VIRUS INFECTION | Merck Sharp & Dohme Corp. (US) | 2013-08-07 | — | — | EP | disclosed |
| WO-2012041014-A1 | TETRACYCLIC INDOLE DERIVATIVES FOR TREATING HEPATITIS C VIRUS INFECTION | MERCK SHARP & DOHME CORP. (US) | 2012-04-05 | — | — | WO | disclosed |
| WO-2012041014-A1 | TETRACYCLIC INDOLE DERIVATIVES FOR TREATING HEPATITIS C VIRUS INFECTION | MERCK SHARP & DOHME CORP. (US) | 2012-04-05 | — | — | WO | disclosed |